https://www.selleckchem.com/pr....oducts/oss-128167.ht
Subgroups of patients with increased systemic oxidative stress might benefit from unspecific antioxidant treatment, but more clinical studies are needed to bring clarity to this issue.In 2016, a project was initiated in Taiwan to adopt molecular diagnosis of childhood medulloblastoma (M. In this study, we aimed to identify a molecular-clinical correlation and somatic mutation for exploring risk-adapted treatment, drug targets, and potential genetic predisposition. In total, 52 frozen tumor tissues of childhood MBs were collected. R
Like
Comment
Share
